Browsing: approval
BiiodicA leading world CDMO, expands his congratulations to Junshi Biosciences (HKEX-1877, SSE-688180), to receiving the approval of new drugs (ind)…
Pembrolizumab, an immune control point inhibitor, has been approved by the US Food and Drug Administration (FDA) for the treatment…
Johnson & Johnson announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib)…